1. Home
  2. Analysis
  3. Equetro
  4. Ondansetron

Equetro and Ondansetron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Equetro (carbamazepine) and Ondansetron (ondansetron). Common drug interactions include abdominal discomfort among females.

The phase IV clinical study analyzes what interactions people have when they take Equetro and Ondansetron. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Equetro?

Equetro has active ingredients of carbamazepine. It is often used in bipolar disorder. eHealthMe is studying from 244 Equetro users. Check the latest studies of Equetro.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.

On Jul, 15, 2026

14 people who take Equetro and Ondansetron together, and have interactions are studied.

Equetro and Ondansetron drug interactions.

What are the common drug interactions of Equetro and Ondansetron, by gender? *:

female:

  1. Abdominal discomfort
  2. Disability
  3. Agitation (state of anxiety or nervous excitement)
  4. Anxiety
  5. Arthralgia (joint pain)
  6. Asthma
  7. Chronic fatigue syndrome (disorder that causes extreme fatigue)
  8. Coeliac disease (simple food intolerance)
  9. Depression
  10. Ear discomfort

male:

n/a

What are the common drug interactions of Equetro and Ondansetron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal discomfort
  2. Arthralgia (joint pain)
  3. Sinus disorder (disease of sinus)
  4. Asthma
  5. Blood pressure increased
  6. Coeliac disease (simple food intolerance)
  7. Disability
  8. Heart rate decreased
  9. Hospitalisation
  10. Intervertebral disc protrusion (spinal disc protrusion)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 85.71%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 85.71%
  3. Drowsiness: 3 people, 21.43%
  4. Asthma: 2 people, 14.29%
  5. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Equetro and Ondansetron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Equetro and Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Equetro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Equetro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ondansetron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine and ondansetron (the active ingredients of Equetro and Ondansetron, respectively), and Equetro and Ondansetron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.